2021
DOI: 10.1097/rlu.0000000000003719
|View full text |Cite
|
Sign up to set email alerts
|

Hepatobiliary Excretion PET/CT With 68Ga-TAoS-DAZA to Evaluate Bile Duct Patency

Abstract: Tri-alkoxysalicyl-1,4-diazepan-6-amine (TAoS-DAZA) ligands, radiolabelled with 68 Ga, have been proposed as PET/CT agents for depiction and quantification of hepatobiliary function and evaluation of bile excretion. In the presented case, a patient with hepatocellulary carcinoma underwent PET/CT with the TAoS-derivate 68 Ga-tri-methoxysalicyl-(TMoS)-DAZA to determine the patency of intrahepatic and extrahepatic bile ducts, in particular of a stent in the common bile duct. The PET/CT was performed without compli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
(16 reference statements)
0
1
0
Order By: Relevance
“…Our group has designed and established the 68 Ga chelator group TAoS-DAZA as a potential hepatobiliary PET imaging agent [ 1 , 13 ]. Recently, we could show that the [ 68 Ga]Ga-TAoS-DAZA complexes are suitable for liver imaging with PET, allowing for biliary stent integrity diagnosis, potentially also for liver function quantification and differential diagnosis of liver nodules [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Our group has designed and established the 68 Ga chelator group TAoS-DAZA as a potential hepatobiliary PET imaging agent [ 1 , 13 ]. Recently, we could show that the [ 68 Ga]Ga-TAoS-DAZA complexes are suitable for liver imaging with PET, allowing for biliary stent integrity diagnosis, potentially also for liver function quantification and differential diagnosis of liver nodules [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%